Disclaimer: I don't own any Pfizer. I'm a 21-year-old with about 3 years in the market. I'm still an amateur investor learning what makes a company a good investment option.
I've been doing some research into new investment options to try and diversify my portfolio a bit, as I'm overweight in the tech/semiconductor sector. I've been reading up on Pfizer as a long-term hold and was curious to hear everyone's thoughts on it.
Right now, it's fairly cheap, closing at $29.10 today (7/15/24). It's got a couple of things going for it that make me interested in potentially buying.
First off, it has a very attractive dividend, at $1.68 a year (5.0891%) it seems like a solid option to invest in and then let grow under its own weight. Secondly, they are working on a new weight-loss drug that is in the late stages of tier 3(?) trials. Other weight-loss drugs have been very profitable (looking at you Ozempic) and Pfizer has a lot of name recognition from during Covid. In theory, it could prove to be a very lucrative addition to their portfolio of drugs and pharmaceuticals.
This is where my lack of education is going to go on full display: the financials of the company. It has a P/E ratio of 0.0 and a profit margin of 22.12%. Pfizer has what I understand to be a high debt/capital percentage at 42.73%, but has beaten earnings expectations over the last 4 quarters (Q2 2023 to Q1 2024).
I try to do thorough research, but I'm not sure how much all of these statistics play in (again, very much an amateur here) but I figured they might be useful pieces of info to have. I've seen a mixture of reviews with a lot of analysts thinking it's either a good buy or a money pit, so I wanted to see what the lovely people of Reddit thought about it.
Thank you in advance for any input or other advice you might have!
All the statistics and other info here are pulled from Fidelity.
Leave a Reply